A month that began with socialist workers rioting worldwide
in time-honored tradition is ending by making rich capitalists of us all. The S&P 500
(^GSPC) rose once more on Thursday and is closing in on a gain of better than 3% in May. That said, this month is concluding more lamb than lion, and futures this morning are only heightening fears of an upcoming June swoon. (Not helped by fresh signs that Japan’s attempt to inflate its way out of two-decades of doldrums is, to the surprise of no economic student, as effective as pushing on a string
(SBUX) fell after being busted for brewing toilet water
but John Thain, he of the $35,000 commodes during the depths of the recession
, is once more flush with cash. His reputation redeemed, the CEO’s CIT Group
(CIT) surged 5.42% to a fresh peak as financials again outperformed. Mr. Than famously liked his honeybees
yet what would the recently crowned Spelling Bee winner
make of Clearwire’s
(CLWR) mysteriously missing “i”
? It can surely now afford to buy a vowel after gaining 29.31% to a fresh best in topping the Nasdaq
(^IXIC) after an analyst upgrade.
This morning in economics, analysts expect improvements in the May Chicago Purchasing Managers’ index at 9:45 a.m. Eastern and this month’s University of Michigan consumer sentiment survey at 9:55 a.m. On the corporate front, Genesco
(GCO) and Graham Corporation
(GHM) are the pick of a quiet day for earnings announcements.
(CTRX): The company is covered at a Market Perform with Wells Fargo.
(CHK): Goldman Sachs gives the stock a Neutral rating.
(CVS): Wells Fargo covers the company at at Outperform.
: Wedbush begins new Neutrals on both Boston Scientific
(BSX) and Medtronic
(MDT) but assigns a more upbeat Outperform on St. Jude Medical
Melco Crown Entertainment
(MPEL): Shares are set an Outperform rating and $30 price objective at Oppenheimer, which expects consistent margin improvement and market-beating growth over upcoming years.
(NSPH): NSPH is a new Buy at Jefferies.
(OSUR): Jefferies has a Buy on the stock.
(PSTI): Citing an impressive pipeline and solid financial footing, MLV & Co begins Buy rated research with a $4.50 price objective.
(SEAS): The recent initial public offering gets picked up at Overweight by Barclays.
(NYSE:TIF): Just in time for tomorrow’s start of the June wedding season, Credit Suisse assigns an Outperform on this recently-surging upscale jewelry outfit.
(MTN): MKM Partners has a Buy on the ski resort stock.
(VRX): BMO Capital resumes Outperform-rated research on VRX.
(See also: Stock Upgrades: There’s No Place Like HomeAway
and Stock Downgrades: Scotts Miracle-Gro Not Hitting Pay Dirt
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.
Copyright 2011 Minyanville Media, Inc. All Rights Reserved.